WELL Health Provides Corporate Update: Core Clinic and SaaS EMR Revenues Prove to be Resilient and Growing While Telehealth Ramps Up Significantly March 13, 2020
WELL Health Announces Upsize of Private Placement Of Convertible Debentures to $11.0 Million To Include Mr. Li Ka-shing March 13, 2020
Coronavirus Declared a Pandemic as Ovation Receives Interest for DermSafe from More Countries with the Coronavirus (COVID-19) March 12, 2020
Japan’s Regulatory Agency, PMDA, Clears RepliCel Life Sciences to Proceed to Final Consultation for Tendon and Skin Cell Therapy Products March 11, 2020
Ovation Steps Up as Supplier to CFL to Help Keep Prospects and Staff Safe In Midst of Worldwide Concern Over COVID-19 (Coronavirus) March 11, 2020
Japan’s Patent Office Issues RepliCel Two New Patents for its Regenerative Medicine Technologies March 10, 2020
EEStor Corporation Provides Default Status Update and Amends Terms of Bridge Financing March 10, 2020
WELL Health Announces Flu Surveillance Partnership with McMaster University and the Public Health Agency of Canada March 10, 2020
Production of Dermal Injectors Delayed by China Work Stoppage Effecting Critical Component March 9, 2020
Search Minerals Receives Funding From Atlantic Canada Opportunities Agency for Cost and Design Studies March 3, 2020
WELL Health Launches “VirtualClinic+”, A Comprehensive Telehealth Program Across Canada March 2, 2020
